Last 7 days
-3.9%
Last 30 days
-27.2%
Last 90 days
-10.6%
Trailing 12 Months
-80.4%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 38.9B | 6.8B | -8.16% | -1.51% | 30.98 | 5.67 | 8.37% | 3.64% |
ILMN | 34.5B | 4.6B | 7.77% | -35.67% | -7.84 | 7.53 | 1.28% | -677.95% |
MTD | 32.4B | 3.9B | 0.40% | 7.77% | 37.17 | 8.27 | 5.43% | 13.46% |
TECH | 11.4B | 1.1B | -1.86% | -32.35% | 43.34 | 10.14 | 8.77% | 24.82% |
MID-CAP | ||||||||
RGEN | 9.1B | 801.5M | -8.02% | -7.39% | 48.92 | 11.35 | 19.54% | 44.95% |
SMALL-CAP | ||||||||
PACB | 2.1B | 128.3M | 2.84% | -4.86% | -6.78 | 16.59 | -1.69% | -73.40% |
ADPT | 1.1B | 185.3M | -9.20% | -39.56% | -5.71 | 6.17 | 20.06% | 3.42% |
NSTG | 417.7M | 127.3M | -10.60% | -72.39% | -2.62 | 3.28 | -12.28% | -38.43% |
QTRX | 404.9M | 105.5M | -8.66% | -62.15% | -4.19 | 3.84 | -4.55% | -67.63% |
BNGO | 323.9M | 27.8M | -21.01% | -54.58% | -2.44 | 11.65 | 54.62% | -83.06% |
CDXS | 260.6M | 138.6M | -27.21% | -80.41% | -7.76 | 1.88 | 32.30% | -57.86% |
HBIO | 128.8M | 113.3M | 4.79% | -47.51% | -13.53 | 1.14 | -4.68% | -3204.17% |
CDXC | 119.3M | 72.0M | -6.98% | -36.25% | -7.23 | 1.66 | 6.82% | 39.11% |
CSBR | 56.3M | 54.1M | -3.61% | -51.28% | 521 | 1.04 | 21.80% | -72.38% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 4.4% | 138,590,000 | 132,717,000 | 135,016,000 | 122,063,000 | 104,754,000 |
S&GA Expenses | 1.1% | 52,172,000 | 51,583,000 | 51,491,000 | 53,630,000 | 49,323,000 |
R&D Expenses | 4.3% | 80,099,000 | 76,767,000 | 70,111,000 | 63,848,000 | 55,919,000 |
EBITDA | -7.1% | -27,880,000 | -26,024,000 | -14,330,000 | -16,687,000 | - |
EBITDA Margin | -2.6% | -0.20 | -0.20 | -0.11 | -0.14 | - |
Earnings Before Taxes | -7.5% | -33,316,000 | -30,985,000 | -18,647,000 | -20,372,000 | -21,090,000 |
EBT Margin | -3.0% | -0.24 | -0.23 | -0.14 | -0.17 | - |
Interest Expenses | 13.3% | 34,000 | 30,000 | 23,000 | 16,000 | 14,000 |
Net Income | -7.7% | -33,592,000 | -31,178,000 | -18,942,000 | -20,567,000 | -21,279,000 |
Net Income Margin | -3.2% | -0.24 | -0.23 | -0.14 | -0.17 | - |
Free Cahsflow | 143.8% | 2,977,000 | -6,793,000 | -29,413,000 | -35,380,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 6.4% | 250 | 235 | 235 | 235 | 246 |
Current Assets | 11.6% | 163 | 146 | 145 | 145 | 162 |
Cash Equivalents | 4.9% | 114 | 109 | 90.00 | 94.00 | 117 |
Inventory | 25.0% | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 |
Net PPE | -3.0% | 23.00 | 23.00 | 24.00 | 23.00 | 21.00 |
Goodwill | -1.3% | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Liabilities | 30.1% | 106 | 81.00 | 76.00 | 77.00 | 82.00 |
Current Liabilities | 53.8% | 49.00 | 32.00 | 30.00 | 29.00 | 33.00 |
Shareholder's Equity | -6.1% | 145 | 154 | 159 | 159 | 164 |
Retained Earnings | -3.1% | -421 | -408 | -398 | -396 | -387 |
Additional Paid-In Capital | 0.6% | 566 | 563 | 558 | 555 | 552 |
Accumulated Depreciation | 3.2% | 39.00 | 38.00 | 37.00 | 36.00 | - |
Shares Outstanding | 0.3% | 66.00 | 66.00 | 65.00 | 65.00 | 65.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 60.6% | 11.00 | 7.00 | -12.90 | -19.01 | -14.27 |
Share Based Compensation | -0.8% | 15.00 | 15.00 | 13.00 | 13.00 | 12.00 |
Cashflow From Investing | 28.9% | -13.58 | -19.09 | -28.78 | -28.97 | -21.42 |
Cashflow From Financing | -138.0% | -0.57 | 2.00 | 2.00 | 2.00 | 4.00 |
99.2%
69.2%
53.9%
Y-axis is the maximum loss one would have experienced if Codexis was unfortunately bought at previous high price.
5.4%
3.2%
-18.5%
-26.5%
FIve years rolling returns for Codexis.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | BAILLIE GIFFORD & CO | reduced | -12.13 | -13,891,800 | 28,941,200 | 0.03% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -9.09 | -2,000 | 4,000 | -% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -33,577 | 112,423 | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | reduced | -99.97 | -19,995 | 5.00 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | - | -4,000 | - | -% |
2023-02-16 | WHITE PINE CAPITAL LLC | added | 53.4 | 155,988 | 1,023,990 | 0.40% |
2023-02-15 | MetLife Investment Management, LLC | unchanged | - | -46,392 | 153,608 | -% |
2023-02-15 | JANE STREET GROUP, LLC | sold off | -100 | -63,000 | - | -% |
2023-02-15 | ALLIANCEBERNSTEIN L.P. | added | 23.88 | -17,582 | 355,418 | -% |
2023-02-15 | HOWE & RUSLING INC | sold off | -100 | -30,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | nantahala capital management, llc | 6.8% | 4,487,782 | SC 13G/A | |
Feb 14, 2023 | casdin capital, llc | 0% | 0 | SC 13G/A | |
Feb 10, 2023 | ark investment management llc | 6.00% | 3,941,985 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.54% | 3,642,208 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.4% | 6,154,933 | SC 13G/A | |
Jan 18, 2023 | baillie gifford & co | 9.46% | 6,210,551 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 5.24% | 3,400,490 | SC 13G | |
Feb 09, 2022 | ark investment management llc | 5.00% | 3,244,040 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.9% | 5,144,949 | SC 13G/A | |
Jan 12, 2022 | baillie gifford & co | 11.07% | 7,182,402 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 0.76 -80.81% | 1.07 -72.98% | 1.68 -57.58% | 3.15 -20.45% | 4.97 25.51% |
Current Inflation | 0.74 -81.31% | 1.02 -74.24% | 1.55 -60.86% | 2.81 -29.04% | 4.38 10.61% |
Very High Inflation | 0.71 -82.07% | 0.95 -76.01% | 1.39 -64.90% | 2.42 -38.89% | 3.69 -6.82% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 17, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Feb 28, 2023 | POS AM | POS AM | |
Feb 27, 2023 | 10-K | Annual Report | |
Feb 27, 2023 | 4 | Insider Trading | |
Feb 27, 2023 | POSASR | POSASR | |
Feb 23, 2023 | 8-K | Current Report | |
Feb 21, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-16 | NICOLS JOHN J | sold | -146,681 | 4.1071 | -35,714 | - |
2023-03-16 | NICOLS JOHN J | acquired | 70,356 | 1.97 | 35,714 | - |
2023-03-15 | NICOLS JOHN J | sold | -146,131 | 4.0917 | -35,714 | - |
2023-03-15 | NICOLS JOHN J | acquired | 70,356 | 1.97 | 35,714 | - |
2023-03-08 | DILLY STEPHEN GEORGE | sold | -122,931 | 4.5552 | -26,987 | see remarks |
2023-03-08 | Norrett Kevin | sold | -37,616 | 4.5552 | -8,258 | chief operating officer |
2023-03-08 | Fitzgerald Margaret Nell | sold | -35,011 | 4.5552 | -7,686 | see remarks |
2023-03-07 | Norrett Kevin | sold | -39,564 | 4.6027 | -8,596 | chief operating officer |
2023-03-07 | Fitzgerald Margaret Nell | sold | -36,821 | 4.6027 | -8,000 | see remarks |
2023-03-07 | DILLY STEPHEN GEORGE | sold | -129,281 | 4.6027 | -28,088 | see remarks |
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Total revenues | $ 138,590 | $ 104,754 | $ 69,056 |
Costs and operating expenses: | |||
Cost of product revenue | 38,033 | 22,209 | 13,742 |
Research and development | 80,099 | 55,919 | 44,185 |
Selling, general and administrative | 52,172 | 49,323 | 35,049 |
Restructuring charges | 3,167 | 0 | 0 |
Total costs and operating expenses | 173,471 | 127,451 | 92,976 |
Income (loss) from operations | (34,881) | (22,697) | (23,920) |
Interest income | 1,441 | 459 | 405 |
Other income (expense), net ($208, $983 and $0 from a related party) | 124 | 1,148 | (156) |
Loss before income taxes | (33,316) | (21,090) | (23,671) |
Provision for income taxes | 276 | 189 | 339 |
Net loss | $ (33,592) | $ (21,279) | $ (24,010) |
Net loss per share, basic (in dollars per share) | $ (0.51) | $ (0.33) | $ (0.40) |
Net loss per share, diluted (in dollars per share) | $ (0.51) | $ (0.33) | $ (0.40) |
Weighted average common stock shares used in computing net loss per share, basic (in shares) | 65,344 | 64,568 | 59,360 |
Weighted average common stock shares used in computing net loss per share, diluted (in shares) | 65,344 | 64,568 | 59,360 |
Product revenue ($514, $0 and $0 from a related party) | |||
Revenues: | |||
Total revenues | $ 116,676 | $ 70,657 | $ 30,220 |
Research and development revenue ($1,245, $1,955 and $900 from a related party) | |||
Revenues: | |||
Total revenues | $ 21,914 | $ 34,097 | $ 38,836 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 113,984 | $ 116,797 |
Restricted cash, current | 521 | 579 |
Financial assets: | ||
Accounts receivable | 31,904 | 24,953 |
Contract assets | 2,116 | 4,557 |
Unbilled receivables | 7,016 | 8,558 |
Total financial assets | 41,036 | 38,068 |
Less: allowances | (163) | (416) |
Total financial assets, net | 40,873 | 37,652 |
Inventories | 2,029 | 1,160 |
Prepaid expenses and other current assets | 5,487 | 5,700 |
Total current assets | 162,894 | 161,888 |
Restricted cash | 1,521 | 1,519 |
Investment in non-marketable equity securities ($13,921 and $12,713 with a related party) | 20,510 | 14,002 |
Right-of-use assets - Operating leases, net | 39,263 | 44,095 |
Right-of-use assets - Finance leases, net | 0 | 17 |
Property and equipment, net | 22,614 | 21,345 |
Goodwill | 3,241 | 3,241 |
Other non-current assets | 350 | 276 |
Total assets | 250,393 | 246,383 |
Current liabilities: | ||
Accounts payable | 3,246 | 2,995 |
Accrued compensation | 11,453 | 11,119 |
Other accrued liabilities | 15,279 | 12,578 |
Current portion of lease obligations - Operating leases | 5,360 | 4,093 |
Deferred revenue ($0 and $245 to a related party) | 13,728 | 2,586 |
Total current liabilities | 49,066 | 33,371 |
Deferred revenue, net of current portion | 16,881 | 3,749 |
Long-term lease obligations - Operating leases | 38,278 | 43,561 |
Other long-term liabilities | 1,371 | 1,311 |
Total liabilities | 105,596 | 81,992 |
Commitments and contingencies (Note 13) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value per share; 5,000 shares authorized, none issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value per share; 100,000 shares authorized; 65,811 and 65,109 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively | 6 | 6 |
Additional paid-in capital | 566,081 | 552,083 |
Accumulated deficit | (421,290) | (387,698) |
Total stockholders’ equity | 144,797 | 164,391 |
Total liabilities and stockholders’ equity | $ 250,393 | $ 246,383 |